Arup Pramanik is the Corporate Vice President Market Access, Therapeutic Areas at Boehringer Ingelheim. His responsibilities in this role include strategic planning, stakeholder engagement, and institutional collaboration, aiming at delivering value-driven solutions that ensure timely access to groundbreaking treatments, aligned with the company´s unwavering commitment to patient-centricity, yet striving to develop approaches that prioritise patient needs and address the complexities of global healthcare systems. Deeply rooted in evidence-based programs and value-driven strategies, Arup´s work is dedicated to enhancing access and delivering meaningful outcomes for patients worldwide.

The Pop In Your Job
Together with internal teams and external stakeholders, I am eager to shape the future of healthcare through innovation and collaboration.

Boehringer Ingelheim is a family-owned company that has been transforming lives in healthcare since 1885. Its approximately 54,500 employees in 130 markets create value through innovation by infusing long-term, sustainable thinking into our Human Pharma and Animal Health units. The company acknowledges the deep and complex ways the lives of humans and animals are interconnected, works on breakthrough therapies, committed to groundbreaking pharmaceutical innovation across our three business units Human Pharma, Animal Health and Biopharmaceutical Contract Manufacturing, co-creating solutions that help millions of people worldwide live longer, healthier lives.